CN100542563C - Treatment is difficult to the ointment of healing of wound - Google Patents
Treatment is difficult to the ointment of healing of wound Download PDFInfo
- Publication number
- CN100542563C CN100542563C CNB2005101115427A CN200510111542A CN100542563C CN 100542563 C CN100542563 C CN 100542563C CN B2005101115427 A CNB2005101115427 A CN B2005101115427A CN 200510111542 A CN200510111542 A CN 200510111542A CN 100542563 C CN100542563 C CN 100542563C
- Authority
- CN
- China
- Prior art keywords
- ointment
- grams
- wound
- healing
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Treatment is difficult to the ointment of healing of wound, relates to the medicine of a kind of treatment and healing of wound, is particularly useful for the healing to chronic ulcer, decubital ulcer and deep wounds.Ointment of the present invention adds Rhizoma Coptidis, Cortex Phellodendri, Myrrha, boric acid, Mel and makes through fully stirring in vaseline.Do not contain treatment raw material in the ointment of the present invention to the human body toxic side effect; be the environment-friendly type medicine all harmless to human body, environment; effect with good antiinflammatory, granulation promoting, protection granulation, epithelial tissue growth; and preparation and easy to use; low price not only has good medical effect but also good social benefit is arranged.
Description
Technical field
Treatment is difficult to the ointment of healing of wound, relates to the medicine of a kind of treatment and healing of wound, is particularly useful for the healing of chronic ulcer, decubital ulcer and deep wounds.
Technical background
Damaged in common at ordinary times chronic ulcer, decubital ulcer, the degree of depth at II °～III ° small-area burn, cutaneous necrosis, and wound reaches subcutaneous fat, muscle deeply, even wound reaches the tendon place, usually such wound is difficult for growth granulation, epithelial tissue, therefore, much all become cureless wound, given patient's life and spirit is made troubles and painful, endangered patient's body health.Wound for the difficult healing of this class, in clinical treatment, usually adopt traditional Chinese medicine, antibiotics and import dressing such as " pacifying general subsides ", " ulcer subsides " to handle,, also can cure some wounds though can solve some problems, but also there is certain defective, do not reach the requirement of clinical treatment work, as: Chinese medicine " HONGYOU GAO " " eight wet cream " etc. all contains heavy metal " Dong Dan ", and it has toxic and side effects, harmful, and easy contaminated environment.And simple use " HONGYOU GAO ", relatively poor to the antiinflammation of wound, share with other drug or with antibiotics, very inconvenient during use, to the wound of the degree of depth also can cause eczema and easily produce irritated, and the granulation poor growth in the wound." pacify general subsides ", import dressing such as " ulcer subsides " in treatment clinical course, wound is had the good moisture preserving effect, can promote epithelial growth.But, to the wound of inflammation is arranged, do not have the effect of antiinflammatory, and, influence the healing of wound almost the do not grow effect of granulation of the wound of deep layer, relatively poor to the effect of the growth of deep layer wound granulation, and price is more expensive.
Goal of the invention
In order to remedy the deficiency of said medicine and dressing; the inventor is through research and the clinical practice of three more than ten years; propose a kind ofly can have antiinflammatory, promote the growth of granulation protective epithelium to chronic ulcer, decubital ulcer, deep wounds; easy to use; harmless, treatment free from environmental pollution is difficult to the ointment of healing of wound.
The present invention mainly be according to the healing rule of chronic ulcer, decubital ulcer, deep wounds promptly the process of " antiinflammatory, granulation promoting, protection, convergence " select medicament categories and prepare.Ointment of the present invention adopts Rhizoma Coptidis, Cortex Phellodendri, Myrrha, boric acid, Mel and vaseline formulated, wherein:
Rhizoma Coptidis: to golden Portugal bacterium, molten courageous and upright streptococcus, anthrax, the tulase various bacteria has stronger inhibitory action, is good antibiotic medicine.
Cortex Phellodendri: with Rhizoma Coptidis identical effect being arranged, is good external application antibiotic medicine.
Myrrha: have diffusing blood and remove silt, pain relieving, promoting muscle growth functions.
Boric acid: have antiinflammatory, anticorrosion, astringent effect.
Mel:, have the effect of detoxifcation, nutrition, protection wound owing to contain compositions such as glucose, oxide, various vitamin, protein, aminoacid, invertase.
Vaseline: as the basic material of ointment of the present invention.
The component of ointment of the present invention is: add Rhizoma Coptidis 3 grams～7 grams in 100 gram vaseline, Cortex Phellodendri 5 grams～12 grams, Myrrha 4 grams～8 grams, boric acid 3 grams～8 grams, Mel 6 grams～15 grams.
The preparation of ointment of the present invention: at first vaseline is melted under 75 ℃～80 ℃ temperature, the Rhizoma Coptidis of sieving, Cortex Phellodendri through 120 orders, do not have in the vaseline of powdered medicine input fusing and fully mix, add Mel more therein then, boric acid fully mixes, and makes ointment after being stirred to cooling.
The characteristics of ointment of the present invention are: do not contain the treatment raw material to the human body toxic side effect in the ointment; be to human body, environmentally friendly environment-friendly type medicine; effect with good antiinflammatory, granulation promoting, the growth of protection granulation and epithelial tissue growth; and preparation and easy to use; low price not only has good medical effect but also has good social benefit.
The specific embodiment
Embodiment 1
At first 100 gram vaseline are melted under 75 ℃ of temperature, fully mixing in the vaseline of the 3 gram Rhizoma Coptidis of sieving, Cortex Phellodendri 12 grams, Myrrha 4 gram powder input fusings through 120 orders, and then add boric acid 3 gram therein, Mel 6 grams fully mix, and be stirred well to cooling, make ointment.
Embodiment 2
100 gram vaseline are melted under 80 ℃ of temperature, fully mixing in the vaseline of Rhizoma Coptidis 7 grams that sieve through 120 orders, Cortex Phellodendri 5 grams, Myrrha 8 gram powder input fusings, and then add boric acid 8 gram therein, Mel 15 grams fully mix, and are stirred well to cooling, make ointment.
Adopt the clinical case introduction of ointment of the present invention:
Add up to case 51 examples, effective percentage is more than 98%.
Claims (1)
1. treatment is difficult to the ointment of healing of wound, it is characterized in that: in 100 gram vaseline, add Rhizoma Coptidis 3 grams～7 grams, and Cortex Phellodendri 5 grams～12 grams, Myrrha 4 grams～8 grams, boric acid 3 grams～8 grams, Mel 6 grams～15 restrain; When ointment prepares, at first vaseline is melted under 75 ℃～80 ℃ temperature, the Rhizoma Coptidis of sieving, Cortex Phellodendri through 120 orders, do not have in the vaseline of powdered medicine input fusing and fully mix, add Mel more therein then, boric acid fully mixes, and make ointment after being stirred to cooling.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101115427A CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101115427A CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1981834A CN1981834A (en) | 2007-06-20 |
| CN100542563C true CN100542563C (en) | 2009-09-23 |
Family
ID=38164865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101115427A Active CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100542563C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111514214B (en) * | 2020-04-29 | 2022-03-29 | 南京新康力医药科技有限公司 | Traditional Chinese medicine composition and application |
-
2005
- 2005-12-15 CN CNB2005101115427A patent/CN100542563C/en active Active
Non-Patent Citations (4)
| Title |
|---|
| 四黄膏合生肌膏治疗慢性溃疡65例. 李淑萍.新中医，第7期. 1994 |
| 四黄膏合生肌膏治疗慢性溃疡65例. 李淑萍.新中医，第7期. 1994 * |
| 慢性溃疡. 广西中医药，第S1期. 1984 |
| 慢性溃疡. 广西中医药，第S1期. 1984 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1981834A (en) | 2007-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272153B (en) | Antibacterial gel and preparation method thereof | |
| CN101862469B (en) | Chitosan derivative quick hemostasis granules and preparation method thereof | |
| CN103191459B (en) | Composite silica gel protective dressing and preparation method thereof | |
| JP6000976B2 (en) | Hemostatic formulation containing Takara-bi extract | |
| CN100542563C (en) | Treatment is difficult to the ointment of healing of wound | |
| CN101306163A (en) | Zhixue shengji powder | |
| CN102652763A (en) | Traditional Chinese medicine preparation for treating burn and scald and preparation method thereof | |
| CN109793757B (en) | Composition for inhibiting growth of skin scar and preparation method and application thereof | |
| CN101361938A (en) | Kibe paste containing natural zingiber oil | |
| US10232004B2 (en) | Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers | |
| CN1240408C (en) | Ointment for treating chilblain | |
| CN1090961C (en) | Process for preparing onychomycosis ointment | |
| CN100536866C (en) | Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin | |
| CN100509032C (en) | Chinese medicinal preparation for treating nasosinusitis and preparation method thereof | |
| CN1903214B (en) | Ointment containing red precipitate | |
| CN101366922B (en) | Proprietary Chinese medicine for treating empyrosis | |
| CN110170007B (en) | Composition for inhibiting pigmentation in skin healing process and preparation method and application thereof | |
| CN1247204C (en) | Medicine for treating beri-beri | |
| CN101391000B (en) | External medicine composition for treating the eczema and preparation method thereof | |
| CN103948660B (en) | Medical bio bressing suppository and its application for treating gynecological disease, prostatic disorders or anorectal disease | |
| CN108420829A (en) | A kind of pet detumescence and promoting granulation cream | |
| CN112274582A (en) | Novel technology for preparing ointment for treating animal wounds | |
| Gv et al. | An integrative ayurvedic approach in management of breast abscess–A case report | |
| CN86104527A (en) | A kind of preparation method of burn paste | |
| CN1386530A (en) | Medicine for treating burn, sore and ulcer and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |